CLINICAL_TRIALS trial_result · 2012-05-31

Clinical Trial Update: A Study of PF-04217903 in Patients With Advanced Cancer [Phase 1]

Phase 1 study update of PF-04217903 in adults with advanced cancer, which was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: Neoplasms | Phase 1 | Status: TERMINATED | Results posted: 2012-05-31